Jeffery J Auletta
Overview
Explore the profile of Jeffery J Auletta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hakim H, Richardson T, Riggs R, Auletta J, DiGerolamo K, Hron J, et al.
Hosp Pediatr
. 2025 Feb;
15(3):237-246.
PMID: 39933563
Objective: Sepsis is associated with significant morbidity and mortality in pediatric hematology, oncology, and transplant (PHOT) patients. This study characterized PHOT patients who developed hospital-onset sepsis more than 12 hours...
2.
3.
Dandoy C, Auletta J, Badia P, Bidgoli A, Daraiseh N, DeSalvo A, et al.
Transplant Cell Ther
. 2025 Jan;
31(3):123-134.
PMID: 39743208
The Engraft Learning Health Network (LHN) aims to improve outcomes for patients undergoing transplant and cellular therapy (TCT) through a collaborative, data-driven approach. Engraft brings together diverse stakeholders, including clinicians,...
4.
5.
Gui G, Ravindra N, Hegde P, Andrew G, Mukherjee D, Wong Z, et al.
Bone Marrow Transplant
. 2024 Nov;
60(2):154-160.
PMID: 39506075
Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection methodology requires optimization. Persistence of mutated NPM1 or FLT3-ITD...
6.
Shaffer B, Gooptu M, DeFor T, Spellman S, Stefanski H, Shaw B, et al.
J Clin Oncol
. 2024 Nov;
43(4):476-478.
PMID: 39504503
No abstract available.
7.
Kaur M, Horowitz M, Mendizabal A, Chen M, Foley A, Auletta J, et al.
Transplant Cell Ther
. 2024 Nov;
31(1):49-57.
PMID: 39489220
Underrepresentation by race and ethnicity in oncology clinical trials, including those of hematopoietic cell transplantation (HCT), is a known challenge. This analysis studied accrual on Blood and Marrow Transplant Clinical...
8.
Gui G, Ravindra N, Hegde P, Andrew G, Mukherjee D, Wong Z, et al.
Bone Marrow Transplant
. 2024 Oct;
60(2):144-153.
PMID: 39455897
Routine genetic profiling of acute myeloid leukemia (AML) at initial diagnosis has allowed subgroup specific prognostication, drug development, and clinical management strategies. The optimal approach for treatment response assessment for...
9.
Gomez-Arteaga A, Chokr N, Auletta J
Bone Marrow Transplant
. 2024 Oct;
60(2):122-127.
PMID: 39433911
In this special issue of Bone Marrow Transplantation, investigators report the impact of IDH1 [1], IDH2 [2], and FLT3-TKD [3] measurable residual disease (MRD) pre-hematopoietic cell transplantation (HCT) in predicting...
10.
Hegde P, Andrew G, Gui G, Ravindra N, Mukherjee D, Wong Z, et al.
Bone Marrow Transplant
. 2024 Oct;
60(2):175-177.
PMID: 39424958
No abstract available.